| Radiotherapy toxicity D De Ruysscher, G Niedermann, NG Burnet, S Siva, AWM Lee, ... Nature reviews Disease primers 5 (1), 13, 2019 | 794 | 2019 |
| The abscopal effect of local radiotherapy: using immunotherapy to make a rare event clinically relevant K Reynders, T Illidge, S Siva, JY Chang, D De Ruysscher Cancer treatment reviews 41 (6), 503-510, 2015 | 633 | 2015 |
| Abscopal effects of radiation therapy: a clinical review for the radiobiologist S Siva, MP MacManus, RF Martin, OA Martin Cancer letters 356 (1), 82-90, 2015 | 490 | 2015 |
| Stereotactic abative body radiotherapy (SABR) for oligometastatic prostate cancer: a prospective clinical trial S Siva, M Bressel, DG Murphy, M Shaw, S Chander, J Violet, KH Tai, ... European urology 74 (4), 455-462, 2018 | 319 | 2018 |
| Stereotactic body radiotherapy versus conventional external beam radiotherapy in patients with painful spinal metastases: an open-label, multicentre, randomised, controlled … A Sahgal, SD Myrehaug, S Siva, GL Masucci, PJ Maralani, M Brundage, ... The Lancet Oncology 22 (7), 1023-1033, 2021 | 306 | 2021 |
| Stereotactic radiotherapy for pulmonary oligometastases: a systematic review S Siva, M MacManus, D Ball Journal of Thoracic Oncology 5 (7), 1091-1099, 2010 | 248 | 2010 |
| Management of metastatic clear cell renal cell carcinoma: ASCO guideline WK Rathmell, RB Rumble, PJ Van Veldhuizen, H Al-Ahmadie, ... Journal of Clinical Oncology 40 (25), 2957-2995, 2022 | 202 | 2022 |
| Safety and survival rates associated with ablative stereotactic radiotherapy for patients with oligometastatic cancer: a systematic review and meta-analysis EJ Lehrer, R Singh, M Wang, VM Chinchilli, DM Trifiletti, P Ost, S Siva, ... JAMA oncology 7 (1), 92-106, 2021 | 166 | 2021 |
| Pooled analysis of stereotactic ablative radiotherapy for primary renal cell carcinoma: A report from the International Radiosurgery Oncology Consortium for Kidney (IROCK) S Siva, AV Louie, A Warner, A Muacevic, S Gandhidasan, L Ponsky, ... Cancer 124 (5), 934-942, 2018 | 164 | 2018 |
| Long-term outcomes and genetic predictors of response to metastasis-directed therapy versus observation in oligometastatic prostate cancer: analysis of STOMP and ORIOLE trials MP Deek, K Van der Eecken, P Sutera, RA Deek, V Fonteyne, AA Mendes, ... Journal of clinical oncology 40 (29), 3377-3382, 2022 | 163 | 2022 |
| Indirect comparisons of efficacy between combination approaches in metastatic hormone-sensitive prostate cancer: a systematic review and network meta-analysis NJ Sathianathen, S Koschel, IA Thangasamy, J Teh, O Alghazo, ... European urology 77 (3), 365-372, 2020 | 160 | 2020 |
| A systematic review of stereotactic radiotherapy ablation for primary renal cell carcinoma. S Siva, D Pham, S Gill, NM Corcoran, F Foroudi BJU international 110, 2012 | 148 | 2012 |
| Radiotherapy for renal cell carcinoma: renaissance of an overlooked approach S Siva, G Kothari, A Muacevic, AV Louie, BJ Slotman, BS Teh, SS Lo Nature Reviews Urology 14 (9), 549-563, 2017 | 142 | 2017 |
| Metastasis-directed therapy in treating nodal oligorecurrent prostate cancer: a multi-institutional analysis comparing the outcome and toxicity of stereotactic body … E De Bleser, BA Jereczek-Fossa, D Pasquier, T Zilli, N Van As, S Siva, ... European urology 76 (6), 732-739, 2019 | 138 | 2019 |
| Stereotactic ablative radiation therapy for oligometastatic renal cell carcinoma (SABR ORCA): a meta-analysis of 28 studies NG Zaorsky, EJ Lehrer, G Kothari, AV Louie, S Siva European urology oncology 2 (5), 515-523, 2019 | 137 | 2019 |
| The emerging role of stereotactic ablative radiotherapy for primary renal cell carcinoma: a systematic review and meta-analysis RJM Correa, AV Louie, NG Zaorsky, EJ Lehrer, R Ellis, L Ponsky, I Kaplan, ... European urology focus 5 (6), 958-969, 2019 | 133 | 2019 |
| Complications from stereotactic body radiotherapy for lung cancer KH Kang, CC Okoye, RB Patel, S Siva, T Biswas, RJ Ellis, M Yao, ... Cancers 7 (2), 981-1004, 2015 | 126 | 2015 |
| Validating and improving CT ventilation imaging by correlating with ventilation 4D‐PET/CT using 68Ga‐labeled nanoparticles J Kipritidis, S Siva, MS Hofman, J Callahan, RJ Hicks, PJ Keall Medical physics 41 (1), 011910, 2014 | 124 | 2014 |
| Stereotactic ablative body radiotherapy for inoperable primary kidney cancer: a prospective clinical trial S Siva, D Pham, T Kron, M Bressel, J Lam, TH Tan, B Chesson, M Shaw, ... BJU international 120 (5), 623-630, 2017 | 121 | 2017 |
| A pattern of early radiation-induced inflammatory cytokine expression is associated with lung toxicity in patients with non-small cell lung cancer S Siva, M MacManus, T Kron, N Best, J Smith, P Lobachevsky, D Ball, ... PloS one 9 (10), e109560, 2014 | 117 | 2014 |
Professor Michael S. HofmanClinician-Scientist, Peter MacCallum Cancer Centre & University of MelbourneEmail được xác minh tại petermac.org